AmiciG., Da RinG., AgostiniA., VeloS., BocciC.Ten years after MIDAS: Icodextrin lights and shadows.Contrib Nephrol2003; 140: 76–81.
2.
MistryC.D., GokalR., PeersE.A randomized multicenter clinical trial comparing isosmolar icodextrin with hyperosmolar glucose solutions in CAPD. MIDAS Study Group. Multicenter Investigation of Icodextrin in Ambulatory Peritoneal Dialysis.Kidney Int1994; 46: 496–503.
3.
WolfsonM., PirainoB., HamburgerR.J., MortonAR, Icodextrin Study Group. A randomized controlled trial to evaluate the efficacy and safety of icodextrin in peritoneal dialysis.Am J Kidney Dis2002; 40: 1055–65.
4.
PosthumaN., ter WeeP.M., DonkerA.J.M., OeP.L., PeersE.M., VerbrughH.A.Assessment of the effectiveness, safety, and biocompatibility of icodextrin in automated peritoneal dialysis.Perit Dial Int2000; 20(Suppl 2): S106–13.
5.
DaviesD.S.Kinetics of icodextrin.Perit Dial Int1994; 14(Suppl 2): S45–51.
6.
GokalR., MoberlyJ., LindholmB., MujaisS.Metabolic and laboratory effects of icodextrin.Kidney Int Suppl2002; 81: S62–71.
7.
MarshallJ., JenningsP., ScottA., FluckR.J., McIntyreC.W.Glycemic control in diabetic PD patients assessed by continuous glucose monitoring system (CGMS).Kidney Int2003; 64: 1480–6.
8.
JohnsonD.W., ArndtM., O'SheaA., WattR., HamiltonJ., VincentK.Icodextrin as salvage therapy in peritoneal dialysis patients with refractory fluid overload.BMC Nephrol2001; 2(1): 2.
9.
GraddenC.W., AhmadR., BellG.M.Peritoneal dialysis: New developments and new problems.Diabet Med2001; 18: 360–3.
